Tectonic Therapeutic, Inc.
(TECX - NASDAQ)
28,75 USD
📋 Profilo Aziendale

Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs).

|